Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives Jesper LindhardsenSøren Lund KristensenOle Ahlehoff Current Opinion 21 August 2015 Pages: 1 - 8
Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? Daniel D. L. BernalLuke R. E. BereznickiGregory M. Peterson Current Opinion 07 November 2015 Pages: 9 - 17
Potential New Agents for the Management of Hyperkalemia David K. PackhamMikhail Kosiborod Review Article 09 July 2015 Pages: 19 - 31
Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis Parijat SenAmartya KunduWilbert S. Aronow Systematic Review 03 July 2015 Pages: 33 - 41
Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study Jean-Philippe ColletChristian Funck-BrentanoGilles Montalescot Original Research Article 19 September 2015 Pages: 43 - 53
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial Stephen J. NichollsRishi PuriSteven E. Nissen Original Research Article 18 September 2015 Pages: 55 - 65
Evolocumab: A Review in Hyperlipidemia Gillian M. Keating Adis Drug Evaluation 07 December 2015 Pages: 67 - 78
Annual Congress of the European Society of Cardiology: August 29–September 2, 2015; London, UK Amitabh Prakash Meeting Report 21 January 2016 Pages: 79 - 82